Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
9.63
-0.27 (-2.73%)
At close: Dec 5, 2025, 4:00 PM EST
10.50
+0.87 (9.03%)
After-hours: Dec 5, 2025, 7:23 PM EST
Tango Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 1,296 | 332 | 1,010 | 639 | 958 | - | |
| Market Cap Growth | 213.41% | -67.13% | 57.94% | -33.25% | - | - | |
| Enterprise Value | 1,178 | 76 | 689 | 287 | 461 | - | |
| Last Close Price | 9.63 | 3.09 | 9.90 | 7.25 | 10.94 | 11.44 | |
| PS Ratio | 16.01 | 7.89 | 27.64 | 25.72 | 25.86 | - | |
| PB Ratio | 6.71 | 1.66 | 3.99 | 2.56 | 2.78 | - | |
| P/TBV Ratio | 8.10 | 1.66 | 3.99 | 2.56 | 2.78 | - | |
| EV/Sales Ratio | 17.72 | 1.81 | 18.87 | 11.53 | 12.45 | - | |
| Debt / Equity Ratio | 0.22 | 0.18 | 0.15 | 0.17 | 0.00 | 0.20 | |
| Debt / FCF Ratio | - | - | - | - | - | 0.11 | |
| Asset Turnover | 0.24 | 0.12 | 0.09 | 0.05 | 0.11 | 0.06 | |
| Quick Ratio | 8.29 | 6.76 | 7.33 | 6.63 | 11.98 | 4.70 | |
| Current Ratio | 8.88 | 6.98 | 7.54 | 6.76 | 12.10 | 4.73 | |
| Return on Equity (ROE) | -51.65% | -57.58% | -40.49% | -36.41% | -30.38% | -223.51% | |
| Return on Assets (ROA) | -24.52% | -25.31% | -17.01% | -14.82% | -10.28% | -24.81% | |
| Return on Capital (ROIC) | -29.88% | -34.47% | -24.50% | -21.80% | -18.52% | -103.69% | |
| Return on Capital Employed (ROCE) | -57.60% | -52.30% | -32.00% | -29.20% | -12.70% | -31.40% | |
| Earnings Yield | -7.75% | -39.26% | -10.08% | -16.92% | -6.08% | - | |
| FCF Yield | -11.32% | -39.85% | -11.84% | -18.27% | -6.41% | - | |
| Buyback Yield / Dilution | -2.50% | -15.50% | -7.69% | -41.40% | -94.50% | -255.37% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.